An Epidemic of Parvovirus B19-Induced Aplastic Crises in Pediatric Patients with Hereditary Spherocytosis Following the Covid-19 Pandemic
A Single-Center Retrospective Study
Bibliographic Data
| ID | 15719409 |
|---|---|
| Authors | Paola Giordano (0000-0002-7762-3500, University of Bari Aldo Moro), Valentina Palladino (0000-0002-3976-6463, University of Bari Aldo Moro), Giuseppe Lassandro (0000-0001-7858-1632, University of Bari Aldo Moro), Stella Spina (0009-0005-0328-7822, University of Bari Aldo Moro), Giancarlo Vecchio (0000-0001-5462-0027, University of Bari Aldo Moro, corresponding author) |
| Year | 2025 |
| Volume | 12 |
| Issue | 6 |
| Pages | 772-772 |
| Publication date | 2025-06-13 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Children (JOURNAL) |
| Journal identifiers | ISSN: 2227-9067 • E-ISSN: 2227-9067 |
| Publisher | Multidisciplinary Digital Publishing Institute (PUBLISHER • CH) |
| DOI | 10.3390/children12060772 |
| PMID | 40564730 |
| OpenAlex | W4411338026 |
| Language | EN |
| References cited | 40 |
Background: Parvovirus B19 is the major cause of transient aplastic crisis in children with hereditary spherocytosis (HS) inhibiting erythropoiesis and leading to a severe drop in hemoglobin levels, requiring hospitalization and transfusional support. During the COVID-19 pandemic, the circulation of non-COVID respiratory viruses, such as parvovirus B19, initially declined but subsequently increased abruptly following the relaxation of containment strategies. Moreover, it remains unclear whether this has resulted in a rise in parvovirus B19-induced aplastic crises among individuals with HS. Methods: This retrospective, single-center study conducted at the Pediatric University Hospital of Bari (Italy) aims to describe the clinical characteristics and frequency of parvovirus B19-induced aplastic crises in pediatric patients with HS before and after the COVID-19 Public Health Emergency of International Concern (PHEIC, 30 January 2020-5 May 2023). The study was divided into four distinct periods: Period A: from 1 December 2018 to 31 December 2019, representing one year before the declaration of the PHEIC; Period B: from 1 June 2023 to 30 June 2024, representing one year after the cessation of the PHEIC; Period C: before 1 December 2018; Period D: from 1 January 2020 to 31 May 2023, which refers to the pandemic period. Results: A total of 30 patients (55% of the study population, n = 55) experienced a parvovirus B19-induced aplastic crisis. The frequency of these crises in Period B was significantly higher than in Period A ( p Conclusions: This study suggests a substantial increase in parvovirus B19-induced aplastic crises among children with HS following the COVID-19 outbreak indicating a potential impact of public health containment strategies on parvovirus B19 infection rates
2019-20 coronavirus outbreak · Coronavirus disease 2019 (COVID-19 · Disease · Hereditary spherocytosis · Infectious disease (medical specialty · Outbreak · Pandemic · Parvovirus · Spherocytosis · Splenectomy · Virus · Dermatological and COVID-19 studies · Erythrocyte Function and Pathophysiology · Medicine · Parvovirus B19 Infection Studies · Immunology · Internal Medicine · Pediatrics · Virology
| Citation velocity | historical |
|---|---|
| Highly cited | No |